Cure rate in the elderly patients with diffuse large B cell lymphoma deteriorates after the age of 80—results from a single-center survey

The prognosis of elderly patients diagnosed with diffuse large B cell lymphoma (DLBCL) is considered to be clearly inferior to that of younger patients. Besides tumor biology and comorbidities, treatment selection due to an assumed reduced tolerability may contribute to this difference. With increas...

Descripción completa

Detalles Bibliográficos
Autores principales: Freudenberger, Felix, Ohler, Anke, Theobald, Matthias, Hess, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960616/
https://www.ncbi.nlm.nih.gov/pubmed/33634349
http://dx.doi.org/10.1007/s00277-021-04461-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960616/
https://www.ncbi.nlm.nih.gov/pubmed/33634349
http://dx.doi.org/10.1007/s00277-021-04461-8

Ejemplares similares